Back to TUDOR INVESTMENT CORP ET AL TUDOR INVESTMENT CORP ET AL

ALXNALXN
12 quarters

Position history for TUDOR INVESTMENT CORP ET ALTUDOR INVESTMENT CORP ET AL's holdings in ALEXION PHARMACEUTICALS INC

TUDOR INVESTMENT CORP ET AL previously held 0 shares of ALXN (ALEXION PHARMACEUTICALS INC), worth $0 as of 2021-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$3.3M

Total Shares Change

-33,592

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q3
Latest
Exited
0
-100.0%
$00.0%
0
2021-Q2
Increased
907,855
+72.0%
$166.8M3.2%
83
2021-Q1
Increased
527,741
+58.3%
$80.7M1.6%
67
2020-Q4
Increased
333,377
+363.0%
$52.1M1.5%
75
2020-Q3
Increased
72,000
+267.4%
$8.2M0.4%
53
2020-Q2
Decreased
19,595
-18.7%
$2.2M0.1%
0
2020-Q1
Decreased
24,097
-64.0%
$2.2M0.2%
0
2019-Q4
Decreased
66,970
-24.8%
$7.2M0.3%
0
2019-Q3
Increased
89,071
+45.4%
$8.7M0.3%
45
2019-Q2
Increased
61,254
+246.9%
$8M0.2%
53
2019-Q1
Decreased
17,655
-47.4%
$2.4M0.1%
0
2018-Q4
New
33,592
-
$3.3M0.1%
37

Other major holders of ALXN: FARALLON CAPITAL MANAGEMENT, L.L.C., JENNISON ASSOCIATES LLC, BAKER BROS. ADVISORS LP, HBK INVESTMENTS L P

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used